← Back
Data updated: Mar 10, 2026
RUBICON
Pharmaceuticals
RUBICON is a generic drug manufacturer with 5 FDA-approved products.
2022
Since
5
Drugs
-
Trials
29
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
CLOMIPHENE CITRATE 2025-12-18
Labeling
FLUTICASONE PROPIONATE 2025-12-16
Manufacturing (CMC)
CLOMIPHENE CITRATE 2025-10-17
CHLORPROMAZINE HYDROCHLORIDE 2025-10-10
CLOMIPHENE CITRATE 2025-10-03
FLUTICASONE PROPIONATE 2025-08-15
FLUTICASONE PROPIONATE 2025-07-18
Labeling
VALSARTAN 2025-06-05
FLUTICASONE PROPIONATE 2025-06-05
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (3)
Company Info
- First Approval
- 2022-07-08
- Latest
- 2025-10-10
- Applications
- 6